KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Cash from Operations (2016 - 2025)

Historic Cash from Operations for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to $2.0 billion.

  • Bristol Myers Squibb's Cash from Operations fell 5553.05% to $2.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $14.2 billion, marking a year-over-year decrease of 680.71%. This contributed to the annual value of $14.2 billion for FY2025, which is 680.71% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Cash from Operations stood at $2.0 billion for Q4 2025, which was down 5553.05% from $6.3 billion recorded in Q3 2025.
  • Bristol Myers Squibb's Cash from Operations' 5-year high stood at $6.3 billion during Q3 2025, with a 5-year trough of $1.9 billion in Q2 2023.
  • For the 5-year period, Bristol Myers Squibb's Cash from Operations averaged around $3.6 billion, with its median value being $3.7 billion (2022).
  • Its Cash from Operations has fluctuated over the past 5 years, first surged by 13228.94% in 2021, then crashed by 5553.05% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Cash from Operations (Quarter) stood at $4.1 billion in 2021, then decreased by 18.51% to $3.3 billion in 2022, then rose by 28.61% to $4.3 billion in 2023, then rose by 4.4% to $4.4 billion in 2024, then tumbled by 55.53% to $2.0 billion in 2025.
  • Its Cash from Operations stands at $2.0 billion for Q4 2025, versus $6.3 billion for Q3 2025 and $3.9 billion for Q2 2025.